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ABSTRACT
Objective: The objective of this study was to analyze different primers that are commonly used in 
epidemiological studies for the detection of Leishmania DNA by PCR, and to compare them to the 
conventional direct parasite search for American cutaneous leishmaniasis (ACL) diagnosis. Mate-
rial and methods: Five pairs of primers, four of them derived from Leishmania kDNA sequences 
(MP3H-MP1L; B1-B2; LBF1-LBR1; 13A-13B), and one derived from the SL RNA (mini-exon) gene 
repeat (LU5A-LB3C), reported previously, were used. Results: The MP3H-MP1L primers were the 
best at amplifying the DNA, detecting 2 fg of Leishmania spp. DNA. The 13A-13B primers presented 
the worst performance, detecting 512 x 103 fg of DNA. Conclusion: The wide variation in the analyti-
cal sensitivity of the primers used in the PCR, and the significant differences from the conventional 
method of ACL diagnosis found in this study, emphasize the importance of standardizing the PCR 
technique, analyzing sensitivity, and selecting suitable oligonucleotide primers.
Keywords: leishmaniasis; polymerase chain reaction; Leishmania; DNA primers.
[Braz J Infect Dis 2011;15(3):204-210]©Elsevier Editora Ltda.
INTRODUCTION
Leishmaniases are infectious-parasitic diseases 
caused by protozoa of the genus Leishmania. 
They are transmitted by the bite of female dip-
terans of the family Psychodidae, subfamily 
Phlebotominae, generally known as sandflies. 
They have a wide spectrum of clinical forms, in-
volving the skin, mucosa, and internal organs.1-3
The leishmaniases are found across four 
continents, and are endemic in 88 countries, 
72 of which are developing countries. It is esti-
mated that there is a global human prevalence 
of 12 million cases, with 600,000 new cases a 
year for visceral forms and 1-1.5 million new 
cases for cutaneous forms.4 In Brazil, American 
Cutaneous Leishmaniasis (ACL) is caused by at 
least six different species of Leishmania, with 
the majority of cases involving Leishmania 
(Viannia) braziliensis,5 especially in the south-
ern region of the country.6
The classic techniques of ACL diagnosis 
have many limitations. Microscopic examina-
tions of skin scrapings, although quick and of 
low cost, have limitations with regard to sen-
sitivity, especially for chronic lesions. In vitro 
culture techniques are susceptible to micro-
biological contamination, and are difficult to 
grow due to the particular requirements of the 
different parasites.7 The Montenegro skin test 
has good specificity, as it activates the delayed 
hypersensitivity mechanism, but cannot distin-
guish between present and past infections. Se-
rological diagnostic techniques using crude an-
tigens have the disadvantage of cross-reactivity 
of Leishmania antigens with antibodies induced 
by other kinetoplastids, such as Trypanosoma 
cruzi.8,9 Furthermore, serological techniques 
have low sensitivity, because of the low antibody 
titers characteristic of ACL.1 Molecular tech-
niques, such as the polymerase chain reaction 
(PCR), offer an alternative approach to finding 
the parasites in clinical samples.10 Because of the 
molecular specificity of PCR, detection and ge-
netic characterization of Leishmania can be car-
ried out simultaneously.11,12
The extensive literature on the molecular 
diagnosis of ACL has provided various alter-
natives, from the use of primers that amplify 
sequences of specific Leishmania species to 
primers that amplify sequences common 
to all the species.13,14 The objective of this study 
was to analyze different PCR primers that are 
commonly used in epidemiological studies for 
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the detection of Leishmania, and to compare them in the 
diagnosis of ACL in biological samples taken from dogs 
and humans in an endemic region.
MATERIALS AND METHODS
Biological samples
Seventy-three DNA samples, all originating from an 
ACL-endemic region, were used in the study. The samples 
were stored at -18°C in the Laboratory of Leishmaniases 
of Universidade Estadual de Maringá. These samples were 
grouped according to the direct parasite search results. 
Twenty-six of the samples came from dogs (from blood, 
lesion scrapings, and lesion biopsies) originating from 
the municipalities of Mariluz, Abatiá, Rio Bonito do Igua-
çu, Santa Cecília do Pavão, and Nova América da Colina 
(all in the State of Paraná, Brazil). Forty-seven samples 
(lesion scrapings) came from humans from the northeast 
region of Paraná, who were treated at the Laboratório de 
Ensino e Pesquisa em Análises Clínicas (LEPAC) of the 
Universidade Estadual de Maringá, for ACL diagnosis.
Blood samples were collected and added to an equal 
volume of ACD solution (25 mM citric acid; 50 mM 
sodium citrate; 81 mM glucose). The material was fro-
zen at -18°C until DNA extraction. The DNA was ex-
tracted from the blood by either the chloroform-phenol 
method15 or the guanidine-phenol method.16 The DNA 
sediment was then resuspended in 50 μL of TE buffer 
(10 mM TRIS; 1 mM EDTA; pH 8.0).
The lesion scraping and biopsy samples were added to 
100 μL of STE buffer (10 mM TRIS; 1 mM EDTA; 0.1 M 
NaCl; pH 8.0). DNA from lesion biopsies was extracted 
using the Puregene® kit (Gentra, USA). For the extraction 
of DNA from lesion-scraping samples, the tubes contain-
ing the material were incubated at 95°C for 30 min in a 
Thermocycler (Biometra PC, Germany), centrifuged at 
13,000 x g for 1 min, and the supernatant was then trans-
ferred to another tube and stored at -18°C until use.
The DNA was quantified by the Quant-iTTM dsDNA HS 
Assay Kit and the QubitTM fluorometer (Invitrogen, USA).
Direct parasite search (DP) 
For the direct parasite search from canine and human sam-
ples, slides of lesion material were stained with Giemsa and 
inspected for the presence of amastigote forms.
Parasites
Promastigote forms of L. (V.) braziliensis (MHOM/BR/1987/
M11272) were cultured in Medium 199 (Invitrogen®, USA) 
containing 10% bovine fetal serum (Invitrogen®, USA), 
20 mM L-glutamine (Invitrogen®, USA), and 1% human 
urine, at 25°C in a B.O.D. incubator (Logen Scientific, Bra-
zil) until they reached the stationary growth phase.
Extraction of Leishmania DNA
The parasites (approximately 50 mL of culture) were washed 
three times by centrifugation (1,600 x g for 10 min) in cold 
phosphate-buffered saline (PBS). The DNA was extracted by 
the guanidine-phenol method,16 resuspended in TE buffer, 
quantified using the Quant-iTTM dsDNA BR Assay Kit and 
the QubitTM fluorometer (Invitrogen, USA), and serially 
diluted (1,024 ng/µL to 0.5 fg/µL) for the PCR primer sen-
sitivity tests.
Polymerase chain reaction (PCR)
Five different kinetoplast and miniexon sequence pairs of 
primers were used: MP3H (5’-GAA CGG GGT TTC TGT 
ATG C-3’) and MP1L (5’-TAC TCC CCG ACA TGC CTC 
TG-3’),17 B1 (5’-GGG GTT GGT GTA ATA TAG TGG-3’) 
and B2 (5’-CTA ATT GTG CAC GGG GAG G-3’),18 LU5A 
(5’-TTT ATT GGT ATG CGA AAC TTC-3’) and LB3C 
(5’-CGT(C/G)CCGAACCCCGTGTC-3’),19 LBF1 (5’-AAA 
TTC GCG TTT TTT GGC CTC CCC G-3’) and LBR1 (5’-
GCA TAA ACT AGA GAC GGA ACA GAG-3’),20 and 
13A (5’-GTG GGG GAG GGG CGT TCT-3’) and 13B 
(5’-ATT TTA CAC CAA CCC CCA GTT-3’).21 The reac-
tion medium (25 µL) contained 1 µM of each of the prim-
ers (Invitrogen®, Brazil), 0.2 mM dNTP (Invitrogen®, USA), 
1 U Taq DNA polymerase (Invitrogen®, USA), 1.5 mM 
MgCl2, 1X enzyme buffer, and 2 µL of the extracted DNA. 
The amplification was carried out in a PC Thermocycler 
(Biometra, Germany), using an initial heating of 95°C for 
5 min. Each cycle was divided into three stages: denatur-
ation (95°C – 1.5 min), annealing, and elongation (72°C – 
2 min). The PCR conditions were optimized for each of the 
five primer sets to detect L. (V.) braziliensis DNA template. 
Table 1 summarizes the specifications for each protocol 
used in the PCR. After the reaction, the material was kept 
at 72°C for 10 min, and the amplified product was then 
stored at 4°C until use. The products of the amplification 
were submitted to electrophoresis at 10-15 V/cm in aga-
rose gel, and stained with 0.1 µg/mL ethyl bromide. For 
every five samples amplified, one positive control [L. (V.) 
braziliensis DNA] and one negative control (ultrapure wa-
ter) were added. The presence of bands was then observed 
in a transilluminator (Macro Vue UV-20, Hoefer).
Statistical analysis
Proportions and confidence intervals were calculated by 
Mid-P exact test using OpenEpi version 2.2.1 software, at a 
significance level of 5%.
Ethical aspects
All procedures were performed according to protocols 
approved by the Committee on Research Animal Care of 
Universidade Estadual de Maringá (report 027/2005 and 
070/2005) and the Permanent Ethics Committee in Research 
involving Human Beings (report 451/2007). 
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Table 1. Polymerase chain reaction conditions and results with different pairs of oligonucleotide primers on 
biological samples from dogs and humans with suspected American cutaneous leishmaniasis lesions, according 
to diagnosis by direct parasite search
Characteristic MP3H-MP1L B1-B2 LU5A-LB3C LBF1-LBR1 13A-13B
PCR product kDNA  kDNA SL RNA kDNA kDNA 
  minicircle  minicircle gene repeat minicircle minicircle 
  fragment  of L. region of L. fragment of fragment 
  of L. (Viannia) braziliensis  braziliensis L. (V.) of Leishmania 
  (70 pb) complex complex braziliensis (120 pb) 
   (750 pb) (146-149 pb) (536 pb)
Cycles      
 Annealing 57°C – 1.5 min 60.5°C – 1.5 min 55°C – 1.5 min 58°C – 1.5 min 57°C – 1.5 min
 No. of cycles 30 35 30 26 30
 Sensitivity of  
 PCR with 
2 4 256 64 x 10³ 512 x 10³
 
 L. braziliensis 
 DNA (fg)
Groups    
(biological 
sample) - (P/T)
 Dogs DP+  8/8 4/8 2/8 0/8 0/8 
 (lesion 100% 50.0% 25.0%  0%  0%  
 scraping (95% CI; (95% CI;  (95% CI; (95% CI; (95% CI; 
 and biopsy) 68.77-100.00) 18.41-81.59) 4.43-61.17) 0.0-31.23) 0.0-31.23)
 Dogs DP_ 15/18 14/18 6/18 5/18 6/18 
 (blood) 83.3% 77.8% 33.3%  27.7% 33.3% 
  (95% CI; (95% CI; (95% CI; (95% CI; (95% CI; 
  61.03-95.58) 54.69-92.51) 14.77-56.90) 10.96-51.27) 14.77-56.90)
 Humans DP+  27/27 27/27 26/27 15/27 6/27 
 (lesion 100% 100% 96.3%  55.6% 22.2% 
 scraping)  (95% CI; (95% CI; (95% CI; (95% CI; (95% CI; 
  89.50-100.00) 89.50-100.00) 83.06-99.82) 36.73-73.25) 9.53-40.61)
 Humans DP_  12/20 7/20 0/20 0/20 0/20 
 (lesion 60% 35.0%  0% 0% 0% 
 scraping) (95% CI; (95% CI; (95% CI; (95% CI; (95% CI; 
  37.89-79.39) 16.77-57.30%) 00.00-13.91) 00.00-13.91) 00.00-13.91)
P, positive samples; T, total samples; DP, direct parasite search. 
+, positive results; 
_
, negative results. 
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RESULTS
Sensitivity analysis of the five pairs of primers showed differ-
ent detection limits for Leishmania DNA. The MP3H-MP1L 
pair of primers performed best, detecting 2 fg of Leishmania 
(Viannia) DNA. Conversely, the 13A-13B primers presented 
the worst performance, detecting only 512 x 103 fg of Leish-
mania spp. DNA (Figure 1 and Table 1).
The analyses of eight samples of lesion scrapings and 
biopsies from dogs with ACL lesions that showed positive 
DP results had a positivity rate of 100% for PCR using the 
MP3H-MP1L primers, compared to a positivity rate of 0.0% 
when using the LBF1-LBR1 or 13A-13B primers. Figure 2 
shows amplification in clinical samples using MP3H-MP1L 
primers.
In 18 samples of DNA extracted from the blood of dogs 
with suspected ACL lesions, even though DP produced 
negative results, the positivity rate for PCR when using the 
MP3H-MP1L primers was 83.3%, and 27.7% when using 
the least-sensitive primers (LBF1-LBR1).
In the 27 DNA samples from the ACL lesions of hu-
mans that turned out positive DP results, the positivity rate 
for PCR when using the MP3H-MP1L and B1-B2 primers 
was again 100%. When using the LU5A-LB3C primers, the 
positivity rate was 96.3%. 
In the 20 DNA samples from lesions of humans with 
suspected ACL, that had negative DP results, the positiv-
ity rate for PCR when using the MP3H-MP1L primers was 
60.0%, and with the B1-B2 primers was 35.0%. The PCR 
turned out negative with LU5A-LB3C primers.
The PCR results for canine and human lesion samples 
using the MP3H-MP1L primers proved be the most sensi-
tive, demonstrating superior positivity to those of DP for 
ACL diagnosis: 100% in the canine and human samples 
with PD positive and 12/20 (60.0%) in the samples from 
humans with lesion suspected of the ACL (Table 1).
High rates of positivity were found for PCR, using the 
different primers to amplify DNA from blood samples of 
dogs with suspected ACL lesions from an endemic region, 
especially with the MP3H-MP1L primers, which had a 
positivity rate of 83.3%. The analysis of the lesions of these 
dogs by DP gave negative results.
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Figure 1: Representative gel showing analytical sensitivity 
of PCR using as the template a twofold serial dilution of 
DNA from promastigote forms of L. (V.) braziliensis (MHOM/
BR/1987/M11272). Panel A: 120 bp fragment of the kDNA 
minicircle region of the genus Leishmania, using 13A-13B 
primers. Panel B: 536 bp fragment of the kDNA minicircle 
region of L. (V.) braziliensis, using LBR1-LBF1 primers. 
Panel C: 146-149 bp fragment of the SL RNA gene repeat 
region of the L. braziliensis complex, using LU5A-LB3C 
primers. Panel D: 70 bp fragment of the k-DNA minicircle 
region of the subgenus Leishmania (Viannia), amplified by 
polymerase chain reaction (PCR) using MP3H-MP1L primers. 
Panel E: 750 bp fragment of the kDNA minicircle region of 
species of the L. braziliensis complex, using B1-B2 primers. 
M, 100 bp molecular marker.
Figure 2: Representative gel showing amplification using 
MP3H-MP1L primers in clinical samples. Scraping of human 
and canine cutaneous lesions with positive direct parasite 
search (DP+), scraping of human cutaneous lesions with negative 
direct parasite search (DP-) and blood of dog with 
negative direct parasite search (DP-) of lesion. PC, positive 
control [(DNA from L. (V.) braziliensis (MHOM/BR/1987/
M11272)]; NC, negative control (reaction mixture); M, 100 bp 
molecular marker.
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DISCUSSION
We selected five pairs of primers, four of them derived from 
kDNA sequences and one from SL RNA (mini-exon). 
The kDNA minicircles are present in a very high copy 
number (10,000 per cell), and the SL RNA gene is present 
in the nuclear genome as a tandem repeat sequence of ap-
proximately 200 copies.19 These selected pairs of primers are 
intended to detect L. braziliensis, the main species causing 
ACL in southern Brazil. 
PCR using the MP3H-MP1L primers, which only ampli-
fy fragments of the kDNA of species of the subgenus Leish-
mania (Viannia), proved be very sensitive, being capable 
of detecting 2 fg of DNA, which is similar to the results re-
ported by Lopes17 and Velasquez,15 who detected 0.14 fg and 
0.9 fg of DNA, respectively. The other pair of primers that 
showed good sensitivity was B1-B2, which amplifies frag-
ments of the kDNA of species of the L. braziliensis complex, 
detecting 4 fg of DNA, a value very close to that found by De 
Bruijn and Baker.18
The 13A-13B primers that amplify fragments of the kDNA 
of species of Leishmania showed low efficiency, detecting 
only concentrations higher than 512 pg of DNA. Manna,22 
using these same primers, but with DNA from Leishma-
nia infantum, demonstrated a sensitivity of 1 pg of DNA. 
A more significant value of 10 fg of L. (V.) braziliensis 
DNA was found by Rodger.21 However, these latter authors 
used the DNA hybridization method, which results in high-
er sensitivity and therefore efficiency of the primer. Recently, 
Marcussi20 developed a pair of primers (LBF1-LBR1) capa-
ble of amplifying a specific sequence of the kDNA minicircle 
of L. (V.) braziliensis. Data obtained in the present study us-
ing this pair showed that it was capable of detecting 64 pg 
of DNA, showing greater sensitivity in DNA detection com-
pared to the limit of 4 ng reported by Marcussi.20
The mini-exon gene is of great value to molecular biol-
ogy techniques applied to studies of leishmaniasis; in addi-
tion to the large number of copies in the genome, it contains 
conserved and variable regions that differ among the Leish-
mania complexes.23 Derived from this gene, the LU5A-LB3C 
pair of primers has the ability to amplify fragments of DNA 
from various species of Leishmania of the L. braziliensis 
complex, including L. (V.) braziliensis, L. (V.) guyanensis, 
L. (V.) panamensis, and L (V.) peruviana.21 For this pair of 
primers, the present study showed low sensitivities (256 fg) 
compared to previous studies carried out by Harris,19 study-
ing samples from lesion scrapings from patients in South 
and Central America, and Gomes,24 in dogs in Brazil, with a 
detection level above 1 fg of DNA.
The higher sensitivity obtained with the MP3H-MP1L 
primers can be attributed in part to the smaller size of the 
amplicon, which is amplified more efficiently than larger 
fragments.19 Interestingly, the B1-B2 primers showed the 
same sensitivity (4 fg) as the MP3H-MP1L primers, despite 
the size of the amplicon (750 bp), which is 10-fold larger. 
It is not surprising that LU5A-LB3C primers were less sensi-
tive compared to the primers for kDNA, because there are 
50 times fewer copies of the SL RNA gene than of the kDNA 
minicircle,19 which explains the 100-fold lower sensitivity. 
The differences in sensitivity observed among the several 
reports that have used the same pair of primers, can be ex-
plained by different DNA extraction methods that affect the 
quality of DNA.25
The conclusive laboratory diagnosis of ACL is made by 
demonstrating amastigote forms of the parasite in mate-
rial from scrapings or biopsies from lesions, and samples 
of bone marrow.5 PCR has shown several advantages in the 
diagnosis, clinical characterization, and epidemiology of 
leishmaniases. Several studies of ACL caused by parasites 
of the L. braziliensis complex in Central and South America 
have compared diagnoses by PCR with the conventional 
technique. Except in a few cases, the tests using the 
PCR technique were significantly more sensitive than those 
using parasitological diagnostic methods.13,26 However, there 
is great variation in the sensitivity of PCR, especially in re-
lation to the method of DNA extraction, the choice of the 
oligonucleotide primers,25,27,28 the clinical samples used, and 
the length of infection.16
In the present study, 26 samples from dogs (lesion 
scrapings, biopsy, and blood) and 47 samples from humans 
(lesion scrapings), from an endemic area of ACL caused by 
L. (V.) braziliensis, were tested by PCR using these five pairs 
of primers. PCR using the MP3H-MP1L primers, which 
amplify a fragment of the kDNA minicircle region of the 
subgenus Leishmania (Viannia), showed high positivity in 
human and canine lesions, detecting all samples that had 
positive parasite search. Demonstration of amastigote 
forms of the parasite in material from ACL lesions shows 
low sensitivity. Silveira6 demonstrated that only 59.4% of 
the patients with positive laboratorial diagnostic for ACL 
showed positive direct parasite search in lesions. In this 
way, PCR was significantly more efficient than the PD, de-
tecting DNA in 12/20 (60.0%) human lesion samples with 
negative DP. Although the B1-B2 primers detected higher 
number of infected samples from human than PD, its per-
formance in canine samples was not good. On the other 
hand, PCR carried out with the LU5A-LB3C, in spite of 
a good performance in samples from human lesions with 
positive DP, detected only 25.0% of dog samples with posi-
tive DP and none from human samples with negative DP. 
It is important to emphasize that all canine and human 
samples analyzed had DNA quantities higher than the sen-
sitivity limits to these primers. The presence of sufficient 
quantities of DNA in samples only shows that it was ade-
quate to carry out the assay and the dilution of Leishmania 
DNA template by the host DNA is a fact, but it is impos-
sible to be controlled. PCR inhibitors are a setback in clini-
Primers for Leishmania spp.
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cal samples from different sources, but as all samples from 
DP positive lesions could be detected by MP3H-MP1L, it 
is supposed there were no PCR inhibitors in these samples.
LBF1-LBR1 and 13A-13B primers were less effec-
tive than DP to detect Leishmania DNA in human le-
sion scrapings probably due the small DNA quantities 
in these samples. It shows the importance of the choice 
of the primers pairs mainly to analyze samples that, by 
the characteristics from the samples collection, presents 
small quantities of DNA like lesion scrapings. All lesion 
samples detected by PCR using the less-sensitive prim-
ers were also detected by PCR using the more-sensitive 
primers.
Detection of DNA from Leishmania spp. in the blood 
samples of dogs from an endemic area has been reported 
by several investigators.15,25,29,30 In the present study, all 
PCR primers were capable of detecting Leishmania spp. 
DNA, with different positivity rates, in blood samples 
from dogs with suspected ACL lesions, whereas the 
DP technique produced negative results. All the canine 
blood samples detected by PCR using the less-sensitive 
primers were also detected by PCR using the more-sen-
sitive primers, with the exception of one, which was not 
detected by the LBF1-LBR1 primers but was detected by 
the 13A-13B primers.
The diagnostic positivity rate obtained with PCR 
primers was corroborated by the analytical sensitivity. 
The MP3H-MP1L and B1-B2 primers, both targeting the 
kDNA minicircle, detected smaller quantities of L. (V.) 
braziliensis DNA and they showed higher positivity in 
the diagnosis. The MP3H-MP1L amplify a conserved se-
quence17 and the B1-B2 amplify the entire kDNA minicir-
cles of L. (V.) braziliensis,18 showing that the size of the 
amplicon did not influence the PCR. The LU5A-LB3C 
also showed good positivity, but only in lesion scrapings 
from humans. The other two pairs of primers targeting 
the k-DNA minicircle, 13A-13B for the genus Leishmania 
and LBF1-LBR1 for the species L. (V.) braziliensis, may be 
directed to an unconserved region in the genus and spe-
cies, respectively. More studies are necessary with a larger 
number of Leishmania isolates, to establish the real am-
plitude of DNA detection for the latter pairs of primers.
CONCLUSION
In light of these results, it can be concluded that the PCR 
primers used in the diagnosis and epidemiology of cuta-
neous leishmaniasis showed a wide variation in sensitivity. 
Of the pairs of primers analyzed, MP3H-MP1L and B1-B2, 
targeting the kDNA minicircles, performed best. Compared 
to the direct parasite search, however, they performed sig-
nificantly better, emphasizing the importance of standard-
izing the PCR technique, analyzing sensitivity, and choosing 
appropriate oligonucleotide primers.
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